Uncovering the mode of action of engineered T cells in patient cancer organoidsA Living Biobank of Breast Cancer Organoids Captures Disease HeterogeneityPatient-Derived Ovarian Cancer Organoids Mimic Clinical Response and Exhibit Heterogeneous Inter- and Intrapatient Drug ResponsesAn organoid platform for ovarian cancer captures intra- and interpatient heterogeneityTargeted inhibition of Wnt signaling with a Clostridioides difficile toxin B fragment suppresses breast cancer tumor growthLong-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoidsAssessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoidsThree-dimensional single-cell imaging for the analysis of RNA and protein expression in intact tumour biopsies
author
type
label
Oded Kopper